The DOI matches its Crossref record, with a small difference in title or year; 22 of the 24 references it cites were found in a registry or an index.
Prevalence of hypogonadism in males aged at least 45 years: the HIM study
Open accessAbstract
The Hypogonadism in Males study estimated the prevalence of hypogonadism [total testosterone (TT) < 300 ng/dl] in men aged > or = 45 years visiting primary care practices in the United States. A blood sample was obtained between 8 am and noon and assayed for TT, free testosterone (FT) and bioavailable testosterone (BAT). Common symptoms of hypogonadism, comorbid conditions, demographics and reason for visit were recorded. Of 2162 patients, 836 were hypogonadal, with 80 receiving testosterone. Crude prevalence rate of hypogonadism was 38.7%. Similar trends were observed for FT and BAT. Among men not receiving testosterone, 756 (36.3%) were hypogonadal; odds ratios for having hypogonadism were significantly higher in men with hypertension (1.84), hyperlipidaemia (1.47), diabetes (2.09), obesity (2.38), prostate disease (1.29) and asthma or chronic obstructive pulmonary disease (1.40) than in men without these conditions. The prevalence of hypogonadism was 38.7% in men aged > or = 45 years presenting to primary care offices.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Testosterone deficiency is highly prevalent, with rates increasing with age from 4% in men aged 40–49 years to nearly 50% in men over 80 years of age, with some studies suggesting a 17% increase in testosterone deficiency for every decade of life (2-4).”
From Non-testosterone management of male hypogonadism: an examination of the existing literature (2020) · cites this paper as [4]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Gray, A., Feldman, H. A., McKinlay, J. B., & Longcope, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,104
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Araujo, A. B., O’Donnell, A. B., Brambilla, D. J., Simpson, W. B., Longcope, C., Matsumoto, A. M., & McKinlay, J. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031719 · Cited by 591
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men
Bèlanger, A., Candas, B., Dupont, A., Cusan, L., Diamond, P., Gomez, J.-L., & Labrie, F. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962278 · Cited by 437
Petak, S. M., Nankin, H. R., Spark, R. F., Swerdloff, R. S., Rodriguez‐Rigau, L. J., Anderson, R. J., Bergman, D. A., Garber, J. R., Hamilton, C. R., Hershon, K. S., et al. (2002) · Endocrine Practice · doi:10.4158/ep.8.6.439 · Cited by 372
ZUMOFF, B., STRAIN, G. W., MILLER, L. K., ROSNER, W., SENIE, R., SERES, D. S., & ROSENFELD, R. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-929 · Cited by 349
Blood Testosterone Threshold for Androgen Deficiency Symptoms
Kelleher, S., Conway, A. J., & Handelsman, D. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0143 · Cited by 273
Gapstur, S. M., Gann, P. H., Kopp, P. A., Colangelo, L. A., Longcope, C., & Liu, K. (2002) · PubMed · Cited by 247
Research works printed but not linked: 2
- Population Division US Census Bureau, 2005, Table 2: Annual estimates of the population by sex and selected age groups for the United States: April 1, 2000 to July 1, 2003 (NC-EST2003-02)
- Centers for Disease Control, 2005, About minority health
Cited by
Sorted by citations
Items 201–300 of 765
Metabolic syndrome and hypogonadism – two peas in a pod
Ebrahimi, F., & Christ‐Crain, M. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14283 · Cited by 32
Serum Testosterone and Cognitive Function in Ageing Male: Updating the Evidence
Giagulli, V. A., Guastamacchia, E., Licchelli, B., & Triggiani, V. (2016) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/1872214810999160603213743 · Cited by 32
Enclomiphene citrate for the treatment of secondary male hypogonadism
Rodríguez, K. M. G., Pastuszak, A. W., & Lipshultz, L. I. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1204294 · Cited by 32
Sesti, F. F., Pofi, R., Minnetti, M., Tenuta, M., Gianfrilli, D., & Isidori, A. M. (2020) · Andrology · doi:10.1111/andr.12876 · Cited by 31
Desai, A., Yassin, M., Cayetano-Alcaráz, A. A., Tharakan, T., Jayasena, C. N., & Minhas, S. (2022) · Therapeutic Advances in Urology · doi:10.1177/17562872221105017 · Cited by 34
Hypogonadism, Erectile Dysfunction, and Type 2 Diabetes Mellitus: What the Clinician Needs to Know
Tamler, R., & Deveney, T. K. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.11.2234 · Cited by 31
Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS)
Bhattacharya, R. K., Khera, Blick, G., Kushner, H., & Miner, M. M. (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s32036 · Cited by 30
Risk Factors for Hypogonadism in Male Patients with Type 2 Diabetes
Zheng, R., Cao, L., Cao, W., Chu, X., Hu, Y., Zhang, H., Xu, J., Sun, H., Bao, W., Liu, K., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/5162167 · Cited by 31
Grober, E. D., Khera, M., Soni, S. D., Espinoza, M. G., & Lipshultz, L. I. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901618 · Cited by 30
Visceral fat dysfunction is positively associated with hypogonadism in Chinese men
Wang, N., Zhai, H., Han, B., Qin, L., Chen, Y., Chen, Y., Xia, F., Lin, D., & Lu, Y. (2016) · Scientific Reports · doi:10.1038/srep19844 · Cited by 29
Nutalapati, S., Ghagane, S. C., Nerli, R. B., Jali, M. V., & Dixit, N. S. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.039 · Cited by 29
Androgen Deficiency in Aging and Metabolically Challenged Men
Shelton, J. B., & Rajfer, J. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.09.007 · Cited by 30
Almehmadi, Y., Yassin, A. A., Nettleship, J. E., & Saad, F. (2015) · Arab Journal of Urology · doi:10.1016/j.aju.2015.10.002 · Cited by 31
Korneyev, I. A., Alexeeva, T. A., Al-Shukri, S. H., Bernikov, A. N., Еркович, А. А., Kamalov, A. A., Коган, М. И., Павлов, В. Н., Журавлев, В. Н., & DIu, P. (2016) · International Journal of Impotence Research · doi:10.1038/ijir.2016.8 · Cited by 29
Treatment of hypogonadotropic male hypogonadism: Case-based scenarios
Crosnoe-Shipley, L. (2015) · World Journal of Nephrology · doi:10.5527/wjn.v4.i2.245 · Cited by 29
Ugwu, T. E., Ezeani, I. U., Onung, S. I., Kolawole, B. A., & Ikem, R. T. (2016) · Advances in Endocrinology · doi:10.1155/2016/9753154 · Cited by 28
Masterson, T. A., Molina, M. L., Ibrahim, E., & Ramasamy, R. (2018) · European Urology Focus · doi:10.1016/j.euf.2018.08.009 · Cited by 28
Malik, R. D., Lapin, B. R., Wang, C. E., Lakeman, J. C., & Helfand, B. T. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12730 · Cited by 28
Stem cell therapy for the treatment of Leydig cell dysfunction in primary hypogonadism
Peak, T. C., Haney, N. M., Wang, W., DeLay, K. J., & Hellstrom, W. J. G. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i10.306 · Cited by 28
Zhang, K., Chen, Y., Liu, L., Lu, M., Cheng, J., Gao, F., Wang, N., Shen, Z., & Lu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-16108-8 · Cited by 28
Systematic review of hormone replacement therapy in the infertile man
Meliegy, A. E., Motawi, A. T., & Salam, M. A. A. E. (2017) · Arab Journal of Urology · doi:10.1016/j.aju.2017.11.011 · Cited by 28
Androgen regulation of behavioral stress responses and the hypothalamic-pituitary-adrenal axis
Zuloaga, D. G., Lafrican, J. J., & Zuloaga, K. L. (2024) · Hormones and Behavior · doi:10.1016/j.yhbeh.2024.105528 · Cited by 30
Smith, R. P., Khanna, A., Coward, R. M., Rajanahally, S., Kovac, J. R., Gonzales, M., & Lipshultz, L. I. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12226 · Cited by 28
Effect of Opioids on Testosterone Levels: Cross-Sectional Study using NHANES
Cepeda, M. S., Zhu, V. J., Vorsanger, G., & Eichenbaum, G. M. (2015) · Pain Medicine · doi:10.1111/pme.12843 · Cited by 27
Testosterone deficiency: myth, facts, and controversy.
Miner, M. M., Barkin, J., & Rosenberg, M. T. (2014) · PubMed · Cited by 27
Smith, I., Salazar, I., RoyChoudhury, A., & St‐Onge, M. (2019) · Sleep Health · doi:10.1016/j.sleh.2019.07.003 · Cited by 27
Testosterone deficiency and the metabolic syndrome
Lunenfeld, B. (2007) · The Aging Male · doi:10.1080/13685530701390800 · Cited by 27
An update on the role of testosterone replacement therapy in the management of hypogonadism
Hackett, G. I. (2015) · Therapeutic Advances in Urology · doi:10.1177/1756287215617648 · Cited by 26
Salman, M., Yassin, D., Shoukfeh, H., Nettleship, J. E., & Yassin, A. A. (2017) · The Aging Male · doi:10.1080/13685538.2016.1260107 · Cited by 26
Liu, C., Lee, Y., Wang, C., Yeh, H., Li, W., Wu, W., Huang, C., Bao, B., Huang, C., & Huang, S. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02672.x · Cited by 26
Rosen, R. C., de Araújo, A. B., Connor, M. K., Elstad, E. A., McGraw, S. A., Guay, A. T., Morgentaler, A., & Miner, M. M. (2009) · The Aging Male · doi:10.1080/13685530903184043 · Cited by 26
Félix-Patrício, B., Miranda, A. F., Medeiros, J. L., GALLO, C. B. M., Gregório, B. M., de Souza, D. B., Costa, W. S., & Sampaio, F. J. B. (2017) · International braz j urol · doi:10.1590/s1677-5538.ibju.2016.0484 · Cited by 26
Kavoussi, P. K., Machen, G. L., Wenzel, J. L., Ellis, A. M., Kavoussi, M., Kavoussi, K. M., & Kavoussi, S. K. (2018) · Urology · doi:10.1016/j.urology.2018.11.009 · Cited by 26
Luigi, L. D., Sgrò, P., Fierro, V., Bianchini, S., Battistini, G., Magini, V., Jannini, E. A., & Lenzi, A. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01694.x · Cited by 25
The Role of Testosterone Therapy in the Setting of Prostate Cancer
Rodríguez, K. M. G., Pastuszak, A. W., & Khera, M. (2018) · Current Urology Reports · doi:10.1007/s11934-018-0812-1 · Cited by 25
Male sexual dysfunction in obesity: The role of sex hormones and small fibre neuropathy
Ho, J. H., Adam, S., Azmi, S., Ferdousi, M., Liu, Y., Kalteniece, A., Dhage, S. S., Keevil, B. G., Syed, A. A., Ammori, B. J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221992 · Cited by 27
Obstructive Sleep Apnea and Testosterone Therapy
Payne, K. S., Lipshultz, L. I., Hotaling, J. M., & Pastuszak, A. W. (2020) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2020.04.004 · Cited by 25
Chang, Y., Chen, Y., & Kang, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168776 · Cited by 27
Pastuszak, A. W., Gittelman, M., Tursi, J. P., Jaffe, J. S., Schofield, D., & Miner, M. M. (2021) · Andrology · doi:10.1111/andr.13108 · Cited by 28
Relationship between insulin and hypogonadism in men with metabolic syndrome
Caldas, A. D. A., Porto, A. L. A., da Motta, L. D. C., & Casulari, L. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000800015 · Cited by 25
Kaufman, J. M., Miller, M. G., Fitzpatrick, S. B., McWhirter, C. L., & Brennan, J. J. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02630.x · Cited by 25
Self-citationControversies in Testosterone Therapy
Twitchell, D. K., Pastuszak, A. W., & Khera, M. (2020) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2020.09.004 · Cited by 27
Vollert, J., Trewartha, N., Kemkowski, D., Cremer, A. F., Zahn, P. K., Segelcke, D., & Pogatzki-Zahn, E. M. (2022) · European Journal of Pain · doi:10.1002/ejp.2014 · Cited by 24
The Direct and Indirect Costs among U.S. Privately Insured Employees with Hypogonadism
Kaltenboeck, A., Foster, S. A., Ivanova, J. I., Diener, M. D., Bergman, R., Birnbaum, H. G., Kinchen, K., & Swindle, R. W. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02810.x · Cited by 24
Cunningham, G. R. (2013) · Endocrine Practice · doi:10.4158/ep13217.ra · Cited by 24
Essential role of brain-derived neurotrophic factor (bdnf) in diabetic erectile dysfunction
Hu, L., Shao-wu, Q. I., Zhang, K., & Fu, Q. (2017) · Andrologia · doi:10.1111/and.12924 · Cited by 22
Metabolic patterns in insulin-sensitive male hypogonadism
Fanelli, G., Gevi, F., Belardo, A., & Zolla, L. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0588-8 · Cited by 23
Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient Management
Hernández-Cerdá, J., Bertomeu‐González, V., Zuazola, P., & Cordero, A. (2020) · Vascular Health and Risk Management · doi:10.2147/vhrm.s223331 · Cited by 27
12-Month Observation of Testosterone Replacement Effectiveness in a General Population of Men
Miner, M. M., Bhattacharya, R. K., Blick, G., Kushner, H., & Khera, M. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.03.2637 · Cited by 25
Baseline Data from the TRiUS Registry: Symptoms and Comorbidities of Testosterone Deficiency
Miner, M. M., Khera, M., Bhattacharya, R. K., Blick, G., & Kushner, H. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.05.2280 · Cited by 23
Testosterone therapy and prostate cancer
Pastuszak, A. W., Rodríguez, K. M. G., Nguyen, T. M., & Khera, M. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.08.17 · Cited by 23
Santos, H. O., Cadegiani, F., & Forbes, S. C. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.06.006 · Cited by 27
Association of Male Hypogonadism With Risk of Hospitalization for COVID-19
Dhindsa, S., Champion, C. D., Deol, E. S., Lui, M., Campbell, R. G., Newman, J., Yeggalam, A., Nadella, S., Ahir, V., Shrestha, E., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.29747 · Cited by 24
Behnaz, M., Majd, Z., Radfar, M., Ajami, H., Qorbani, M., & Kokab, A. (2017) · Spinal Cord · doi:10.1038/sc.2017.73 · Cited by 22
A new 2% testosterone gel formulation: a comparison with currently available topical preparations
Arver, S., Stief, C. G., de la Rosette, J. J. M. C. H., Jones, T. H., Neijber, A., & Carrara, D. (2018) · Andrology · doi:10.1111/andr.12487 · Cited by 23
Assyov, Y. S., Gateva, A., Karamfilova, V., Gatev, T., Nedeva, I., Velikova, T. V., & Kamenov, Z. A. (2020) · The Aging Male · doi:10.1080/13685538.2020.1770721 · Cited by 24
Syed, A. A. S., He, L., & Shi, Y. (2020) · Genes · doi:10.3390/genes11070721 · Cited by 25
Efficacy of Non-Testosterone-Based Treatment in Hypogonadal Men: A Review.
Raheem, O. A., Chen, T., Akula, K. P., Greenberg, J., Le, T. V., Chernobylsky, D., Sikka, S. C., & Walsh, T. J. (2021) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2020.08.003 · Cited by 22
Grober, E. D., Krakowsky, Y., Khera, M., Holmes, D. T., Jc, L., Grantmyre, J. E., Patel, P., Bebb, R. A., Fitzpatrick, R., Campbell, J. D., et al. (2021) · Canadian Urological Association Journal · doi:10.5489/cuaj.7252 · Cited by 26
Weldesenbet, A. B., Kebede, S. A., & Tusa, B. S. (2021) · Journal of International Medical Research · doi:10.1177/0300060521993318 · Cited by 22
Guay, A., Miller, M. G., & McWhirter, C. L. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901580 · Cited by 22
Self-citationHigh Prevalence of Prolonged QT Interval in Obese Hypogonadal Males
Giraldi, F. P., Manzoni, G., Michailidis, J., Scacchi, M., Stramba‐Badiale, M., & Cavagnini, F. (2011) · Obesity · doi:10.1038/oby.2011.33 · Cited by 22
Oxidative Stress, Nutritional Antioxidants, and Testosterone Secretion in Men
Mj, G., & Smith, K. (2015) · Cited by 21
Testosterone replacement in the infertile man
Majzoub, A. A., & Sabanegh, E. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.08.03 · Cited by 22
Contreras, P. H., Serrano, F. G., Salgado, A. M., & Pilar Vigil, P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00190 · Cited by 22
Liao, C., Huang, C., Li, H., Yu, H., Chiang, H., & Liu, C. (2011) · The Aging Male · doi:10.3109/13685538.2011.597462 · Cited by 22
Madhu, S. V., Aslam, M., Aiman, A., Siddiqui, A. A., & Dwivedi, S. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.195999 · Cited by 22
Men’s Health in Primary Care: An Emerging Paradigm of Sexual Function and Cardiometabolic Risk
Miner, M. M. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.09.003 · Cited by 21
Testosterone Replacement Therapy: A Narrative Review with a Focus on New Oral Formulations
Bhat, S. Z., & Dobs, A. S. (2022) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2022.18.2.133 · Cited by 23
Delivering Enhanced Testosterone Replacement Therapy through Nanochannels
Ferrati, S., Nicolov, E., Bansal, S. S., Zabre, E., Geninatti, T., Žiemys, A., Lee, H., Mauro Ferrari, B., Goodall, R., Khera, M., et al. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400348 · Cited by 21
Hassan, J., & Barkin, J. (2016) · PubMed · Cited by 21
Testosterone Replacement Therapy and Components of the Metabolic Syndrome
Anaissie, J. E., Roberts, N. H., Wang, P., & Yafi, F. A. (2017) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.01.003 · Cited by 21
Fillo, J., Breza, J., Jr., Levčíkova, M., Luha, J., Vachulová, A., Durdík, Š., & Labaš, P. (2012) · International Urology and Nephrology · doi:10.1007/s11255-012-0132-1 · Cited by 21
Male gonadal axis function in patients with type 2 diabetes
Costanzo, P., & Knoblovits, P. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0014 · Cited by 21
Stahlman, J., Britto, M. R., Fitzpatrick, S. B., McWhirter, C. L., Testino, S. A., Brennan, J. J., & ZumBrunnen, T. L. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.652731 · Cited by 21
Self-citationErectile Dysfunction among Diabetic Patients in a Tertiary Hospital of Southwest Ethiopia
Hurisa, A. D., & Negera, G. Z. (2020) · The Open Public Health Journal · doi:10.2174/1874944502013010240 · Cited by 20
Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect
Tamargo, J. L., Pérez‐Villacastín, J., Caballero, R., & Delpón, E. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107077 · Cited by 22
Vasectomy Reversal Outcomes in Men Previously on Testosterone Supplementation Therapy
Coward, R. M., Mata, D. A., Smith, R. P., Kovac, J. R., & Lipshultz, L. I. (2014) · Urology · doi:10.1016/j.urology.2014.06.081 · Cited by 20
Lower urinary tract symptoms and metabolic disorders: ICI-RS 2014
Denys, M., Anding, R., Tubaro, A., Abrams, P., & Everaert, K. (2016) · Neurourology and Urodynamics · doi:10.1002/nau.22765 · Cited by 20
Li, J., Lai, H. C., Chen, S., Zhu, H., & Lai, S. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.10.022 · Cited by 19
Lundy, S. D., Parekh, N. V., & Shoskes, D. A. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.03.006 · Cited by 21
Ferro, M., Lucarelli, G. T., COBELLI, O. D., Vartolomei, M. D., Damiano, R., Cantiello, F., Crocerossa, F., Perdonà, S., Prete, P. D., Cordima, G., et al. (2020) · World Journal of Urology · doi:10.1007/s00345-020-03368-9 · Cited by 20
Clinical Manual of Sexual Disorders
Balon, R., & Segraves, R. T. (2010) · Cited by 20
Population‐based patterns of prescription androgen use, 1976–2008
Hall, S. A., Ranganathan, G., TINSLEY, L. J., Lund, J. L., Kupelian, V. A., Wittert, G., Kantoff, P. W., Morales, Á., & de Araújo, A. B. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3579 · Cited by 19
Interleukin-18 and testosterone levels in men with metabolic syndrome
Angelova, P., Kamenov, Z. A., Tsakova, A. D., El‐Darawish, Y., & Okamura, H. (2017) · The Aging Male · doi:10.1080/13685538.2017.1401993 · Cited by 18
The Impact of Obesity on Benign and Malignant Urologic Conditions
Chu, K. F., Rotker, K. L., & ELLSWORTH, P. I. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.07.2679 · Cited by 19
Moon, D. G., Kim, J. W., Kim, J. J., Park, K., Park, J. K., Park, N. C., Kim, S. W., & Lee, S. W. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12393 · Cited by 19
Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism
Earl, J. A., & Kim, E. D. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1612239 · Cited by 19
Kaplan, S. A., O’Neill, E. A., Lowe, R., Hanson, M. E., & Meehan, A. G. (2013) · The Aging Male · doi:10.3109/13685538.2013.773421 · Cited by 19
Mousavi, S. A.-J., Kouchari, M.-R., Samdani-Fard, S. H., Gilvaee, Z. N., & Arabi, M. (2012) · Europe PMC (PubMed Central) · Cited by 19
Alrabadi, N., Al-Rabadi, G. J., Maraqa, R., Sarayrah, H., Alzoubi, K. H., Alqudah, M., & Al-U'datt, D. G. F. (2020) · Andrologia · doi:10.1111/and.13730 · Cited by 18
Marrachelli, V. G., Miranda, F. J., Centeno, J. M., Salom, J. B., Torregrosa, G., Jover‐Mengual, T., Pérez, A. M., Moro, M. Á., & Alborch, E. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.06.008 · Cited by 17
Fisher, W. A., Gruenwald, I., Jannini, E. A., Lev‐Sagie, A., Löwenstein, L., Pyke, R. E., Reisman, Y., Revicki, D. A., & Aurioles, E. R. (2017) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.08.016 · Cited by 18
Yu, F., Zhang, Q., Dai, D., Ying, H., & Dai, Y. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04693.x · Cited by 18
Matsumoto, A. M., & Bremner, W. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00019-8 · Cited by 18
Matsumoto, A. M., & Bremner, W. J. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00019-5 · Cited by 18
Office Evaluation of Male Sexual Dysfunction
Seftel, A. D., Miner, M. M., Kloner, R. A., & Althof, S. E. (2007) · Urologic Clinics of North America · doi:10.1016/j.ucl.2007.08.004 · Cited by 18
Kamenov, Z. A. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02148.x · Cited by 17
Testosterone Supplementation Therapy in the Treatment of Patients with Metabolic Syndrome
Kovac, J. R., Pastuszak, A. W., Lamb, D. J., & Lipshultz, L. I. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.11.2843 · Cited by 18
Blick, G. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.03.2639 · Cited by 17
Metadata
- Authors
- MULLIGAN, T., FRICK, M. F., ZURAW, Q. C., STEMHAGEN, A., & MCWHIRTER, C.
- Affiliations
- University of Florida (US)
- Covance (United States) (US)
- Solvay (United States) (US)
- Corresponding author
- MULLIGAN, T.
- ORCID
- MULLIGAN, T.
- Venue
- International Journal of Clinical Practice
- Publisher
- Hindawi Limited
- Published
- 2008-10-09
- Volume
- 60
- Issue
- 7
- Pages
- 762-769
- ISSN
- 1368-5031 (ISSN-L)
- PMC
- PMC1569444
- OpenAlex
- W1667402504
- Cited by
- 767
- References
- 24
- Citations by year
- 2026: 14 · 2025: 37 · 2024: 37 · 2023: 32 · 2022: 35 · 2021: 42 · 2020: 44 · 2019: 38 · 2018: 34 · 2017: 54 · 2016: 60 · 2015: 40 · 2014: 58 · 2013: 60 · 2012: 42
- FWCI
- 18.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- International Journal of Clinical Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- hypogonadism, androgen deficiency, prevalence, primary care, free testosterone, bioavailable testosterone, comorbidities, hypertension, hyperlipidemia, diabetes mellitus, obesity, prostate diseases, asthma, chronic obstructive pulmonary disease, testosterone replacement therapy
- MeSH terms
- Aged, Aged, 80 and over, Humans, Hypogonadism, Male, Middle Aged, Testosterone, United States, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review